Over the past three months I, probably like most have benefitted from the movement in small micro - cap stock that have risen heavily on increased liquidity. The next stock, despite having benefitted from a massive surge in share price back in April, that I have focused on is Ultrasis. This company is poised to secure the ever increasing Mental Health Market both at home and in the US (Several lucrative contracts already announced)through its suite of highly effective software.

The companies web address is as follows http://www.ultrasis.co.uk

I for one have gone heavily into this stock and am prepared to wait for the realisation of its potential to kick in .I would advise others to do so

DYOR

I got in today as well - huge rise - not sure why they would go to 6p though - long way from here! 2005 might be kinder to these micro-stocks than last year!

Poverty
Hang in there, still holding.

We shall see a huge rise soon

I'm still here - added today!

bought a few hundred thousand just now @0.69p; a man can watch only so long :)

Welcome aboard pardner! These shares are rising again today - don't know why - but what the h, it's fun! Remember - Shares can go up as well as down!

good news coming soon?

Following two recent news announcements, it's beginning to look like after an extended period of restructuring and cost-cutting, the corner might have been turned for ULT.

ULT has seen decent success in selling it's products in the US. The US health market is now said to be showing signs of emergence from its period of consolidation and change but cost pressures on the US health system remain as a key feature. Nevertheless, ULT has increased its service to Managed Health Network Inc (MHN) and extended the contract through to August 2007 and The Relief Series is now available to more than four million people in the US. "Beating the Blues" has seen its first US success, being successfully used at Emory University Hospital, Atlanta and as a provider in Louisiana. Most recently, in January 2005, Value Options, a US company with 23 million members, announced that they too will license Beating the Blues:



In the UK and possibly further afield, ULT's markets look set to improve markedly over the next 2-3 years. First, two papers on "Beating the Blues"' clinical and cost effectiveness published in the British Journal of Psychiatry have stimulated world wide interest in "Beating the Blues".

Second, in Nov 2004, the Health and Safety Executive (HSE) published new stress management standards targeting over 33,500 companies in the UK with more than 50 employees. The first to feel the impact have been local authorities, who are recognised as having the biggest problem with sickness absence due to stress related problems. The HSE advocates a three stage approach to cutting down stress related absences, which are estimated to result in 13 million working days lost per year. The first stage is establishing if there are problems and where they occur, the second then provides support for staff, with the third and final stage geared to helping those who have developed clinical problems - such as anxiety or depression - get back to work. To meet the audit needs of the first stage in the process, ULT has released Calm Workplace - Work Related Stress Audit (WRSA) which provides employers of all types and sizes with an internet-based easy to implement and cost effective way to help meet the new HSE stress management standard. Calm Workplace - WRSA completes the suite of tools developed by Ultrasis to meet the three pronged approach.

Separately, ULT has recently announced that Kent County Council has placed an order for the provision of Ultrasis' interactive online support programme. This will go live in April and indicates the start of commitment from UK employers and the huge Public Service market in particular.

Following this news, an informative assessment was released on the deal and the company. To read it, click Comment on Kent CC License.

Furthermore, ULT has presented the National Institute of Clinical Excellence (NICE) with new evidence of the efficacy of "Beating the Blues". That evidence is currently under review and their revised report on the use of Computerised Cognitive Behavioural Therapy (CCBT) within the NHS is expected in Summer 2005. Chances are that it will be favourable based on the increasing knowledge and acceptance of computerised therapies among NHS purchasers prompted by new guidelines for the treatment of depression from NICE. Some related links:

Full NICE Guidance.

NICE Review Timetable.

Latest NICE Guidelines for Depression (Feb 05) Recommending That CCBT Can Be Considered For Mild Depression.

Beating the Blues has now been purchased in multi-license form by two Primary Care Trusts namely; Swindon and West Sussex as well as two substantial pilot projects in the North West and East Midland regions where the new Primary Care Graduate Mental Health Workers will be providing "Beating the Blues" as a service to the regions. To read an article on Beating The Blues in use in Swindon and the North West click Beating The Blues in Swindon and the North West. ULT's first NHS implementation of the Relief Series as a pilot in St Helens has attracted a lot of attention including a visit by the Health Minister Rosie Winterton. The pilot is named "Oh What a Relief" and is now set to continue for a further year. For the website and details click Oh What A Relief. If you happen to live or work in the Borough of St Helens, maybe you could register and provide some feedback.

ULT's stated strategy is to focus on professional and corporate markets both in the
UK and the US. It believes that other territories should also begin to open up and that the need for its products is clearly demonstrated by its results and will continue to grow.

On a note of caution for investors, to fund this growth, and to provide additional working capital, the directors have said that they are currently considering various strategies for raising additional finance.

ULT says it has now reached a position where its overheads are controlled. The
Board remains confident that there is a vibrant market for the company's products.

sam who issued this piece,nice one.cheers woodie

seems good news.

I hope they don't release yet more shares - there are a billion knocking around already!

Hmmm, I'm not sure this is generally known but in an area related CCBT, ULT may be using computer-based procedures to target the epilepsy market one day, judging by this patent application published in Jan 2004:

http://www.patent.gov.uk/patent/notices/journals/2004/5984.pdf (Page 48)

It may take some time to load so here's what it says:

"Ultrasis UK Limited Apparatus and systems for the treatment of epilepsy
Date Lodged: 19 Dec 2003 GB0329518.5"

Quite technical, but this paper gives an insight into the patent apparently using a computer generated graphics procedure known as biofeedback:

http://www.fil.ion.ucl.ac.uk/~hugo/yokocnvbehav.pdf

In particular, Page 3:

"2.4. GSR recording

The measurement of GSR and the implementation of biofeedback sessions (BF relax and BF arousal exercises) were undertaken using a biofeedback system (the Inner Tuner: Professional, Ultrasis Plc., London, UK) that had been modified for experimental use. Dry nickel-plated electrodes were placed on the palmar surface of the subjects index and middle finger of their left hand. The area of an electrode was approximately 1 cm2. Skin resistance was measured conventionally between the two electrodes enabling detection of changes in GSR, prompted by thought, emotion or physical tension. A calibration curve for this machine was calculated using standard resistances so that the calibration ensured that the machines response was linear. Biofeedback took the form of computer-generated graphics, presented visually on a computer monitor. Changes in the subjects skin resistance (GSR) resulted in movement through a series of animations which progressed in a positive direction starting with a picture of a jellyfish, then crocodile, dinosaur, ape and man when the subjects GSR changed in the intended direction. Thus, in the BF relax session, the subject watched the evolution of the graphics as GSR sympathetic arousal decreased. The direction of the graphic change was the same for BF arousal except that increasing arousal lead to progression through the pictures."

And here's some background to the origin of the patent:

http://thomsoncurrentdrugs.com/cdmedia/gazettenews/2004/CPG_News_0405.pdf

"Ultrasis plc, now claiming apparatus and systems for treating epilepsy, specializes in computerized, drug-free solutions enabling people to manage their well-being interactively. This is achieved using a combination of cognitive behavioural therapy (CBT), biofeedback and multimedia. This is said to be based on patented technology, but virtually nothing in the published patent literature directly supports the assertion. However, a lone South African application claiming a 1999 Israeli priority serves to link Ultrasis with Ultramind Int Ltd and one of its non-executive directors, Tuvi Orbach. Patenting from Ultramind covers mainly therapy of cardiac and CNS conditions, and our DOLPHIN database serve to link it with a company called Sentitech Ltd."

Significant future development potential I would have thought!

A lot of buyers coming in thick and fast:-D

Tick up on the card soon.

nice post sam now at 70 lets hope it can stay there and rise as this is the third time of trying.cheers woodie

I am here WOODIE to see ULT in double figuers, hopefully soon.

Regards

Sam

Another ticker coming up, another step closer to
the "GOLDEN CROSS".

Double figures - you mean 1.1 or something?

No, I mean Double figures >10p

That really would be something!

Morning all